✦ LIBER ✦
A phase I evaluation of multitargeted antifolate (MTA, LY231514), administered every 21 days, utilizing the modified continual reassessment method for dose escalation
✍ Scribed by David A. Rinaldi; John G. Kuhn; Howard A. Burris; F. Andrew Dorr; Gladys Rodriguez; S. Gail Eckhardt; Suzanne Jones; James R. Woodworth; Sharyn Baker; Connie Langley; David Mascorro; Trent Abrahams; Daniel D. Von Hoff
- Publisher
- Springer
- Year
- 1999
- Tongue
- English
- Weight
- 142 KB
- Volume
- 44
- Category
- Article
- ISSN
- 0344-5704
No coin nor oath required. For personal study only.